2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Thyroid Cancer
Thyroid cancer, while typically treatable, poses challenges due to its varied subtypes and potential for recurrence. Cancer research in this field focuses on refining diagnostic methods and developing targeted therapies to improve patient outcomes. Molecular testing has revolutionized thyroid cancer management, allowing for precise characterization of tumors and personalized treatment strategies. Additionally, immunotherapy and targeted drug therapies show promise in addressing aggressive forms of thyroid cancer resistant to conventional treatments. Clinical trials explore novel approaches, including combination therapies and immunomodulators, aiming to enhance treatment efficacy and minimize side effects. By advancing our understanding of thyroid cancer biology and therapeutic options, ongoing research endeavors strive to provide patients with more effective and tailored interventions, ultimately improving survival rates and quality of life.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China